Consumer health care company Haleon plc has set out its digital ambitions with the establishment of a dedicated incubator business, Haleon NEXT. Described as Haleon’s innovation arm, the new business represents another step forward for the New York and London listed firm, which demerged from parent company GSK plc in 2022.
What has emerged is an independent consumer health business that combines GSK’s product range with those of Novartis AG...